Becton, Dickinson and Co. is increasing its U.S. manufacturing capacity for essential medical devices, including syringes, needles and IV catheters.
As part of a $10 million investment in 2024, new production lines for needles and syringes have been installed at BD's plants in Connecticut and Nebraska, with one line already operational, according to a Jan. 15 news release from the company.
BD is also investing $30 million in 2025 to expand IV catheter production at its Utah facility, following a $2 million investment in 2024 that increased output by 40 million IV catheters per year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.